FDA Approves CELECOXIB — AiPing Pharmaceutical, Inc.

# FDA Approves Generic Celecoxib Application for AiPing Pharmaceutical The FDA has approved ANDA208856 for AiPing Pharmaceutical, Inc.'s generic celecoxib oral formulation, marking the company's entry into the competitive selective COX-2 inhibitor market and likely intensifying price competition in the arthritis and pain management segment. The approval is expected to increase generic alternatives available to patients and providers, potentially reducing treatment costs for celecoxib-dependent prescriptions.